Physician profile
Robert E Mayfield
NPI 1528010097
$3,722.97
in general payments reported to CMS, 2019-2025
34 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $66.45 · 2021: $98.06 · 2022: $19.06 · 2023: $770 · 2024: $1,248 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,277.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $556.18 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $517.48 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $483.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $387.23 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $269.60 | 2019-2025 | |
| Abbott Laboratories | $168.76 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Boston Scientific Corporation | $144.00 | 2019-2025 | General - Pain Management |
| Amgen INC. | $133.62 | 2019-2025 | Otezla, Repatha, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.55 | 2023-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.03 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $86.46 | 2020-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $83.32 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $81.01 | 2024-2025 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.31 | 2024-2025 | Caplyta |
| Merck Sharp & Dohme LLC | $59.46 | 2019-2025 | Capvaxive, Gardasil 9 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $57.15 | 2023 | Exablate |
| Dexcom, INC. | $51.37 | 2024-2025 | Dexcom G6 Transmitter |
| C2n Diagnostics, LLC | $38.32 | 2025 | Precivityad2 |
| Edwards Lifesciences Corporation | $33.44 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Phathom Pharmaceuticals, INC. | $30.76 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $29.62 | 2024 | |
| Astellas Pharma US INC | $29.49 | 2020-2023 | Myrbetriq |
| Dynavax Technologies Corporation | $24.65 | 2023 | Heplisav-B |
| Sanofi-Aventis U.S. LLC | $23.75 | 2024 | |
| Amneal Pharmaceuticals LLC | $22.22 | 2025 | Unithroid |
| Eisai INC. | $19.33 | 2024 | |
| Philips North America LLC | $19.05 | 2024 | (Ck6) Holter |
| Viatris Specialty LLC | $18.96 | 2025 | Yupelri |
| Cequr Corporation | $18.20 | 2024 | Cequr Simplicity |
| Watermark Medical, INC. | $17.64 | 2024 | |
| Lundbeck LLC | $15.33 | 2025 | Rexulti |
| Amarin Pharma, INC. | $14.33 | 2021 | |
| Allergan, INC. | $13.07 | 2020 | |
| Shire North American Group INC | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mayfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.